Beta Drugs Limited: Trading Window Closed Jan 1, 2026 for Q3 FY26 Results

Beta Drugs Limited (BDL) has announced the closure of its trading window for all Directors, Officers, Designated Employees, their immediate relatives, and others covered under the company's Code for P...

Beta Drugs Limited (BDL) has announced the closure of its trading window for all Directors, Officers, Designated Employees, their immediate relatives, and others covered under the company's Code for Prevention of Insider Trading. The trading window will be closed from January 1, 2026, and will reopen 48 hours after the declaration of the Unaudited Financial Results for the quarter ended December 31, 2025. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and NSE circular NSE/CML/2019/11 dated April 2, 2019, regarding trading restriction periods. The company has informed the Listing Department of the National Stock Exchange of India Limited about this development.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Beta Drugs Limited in the news today?

Beta Drugs Limited (BETA) is in the news due to the announcement is a routine regulatory disclosure regarding the closure of the trading window and does not contain any new financial information or business developments that would impact the company's sentiment.

Trading Window Disclosure
Beta Drugs LimitedBETAhttps://prysm.fi/v2/analyze/BETA

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Beta Drugs Limited: Trading Window Closed Jan 1, 2026 for Q3 FY26 Results

December 31, 2025, 09:57 AM

AI Sentiment Analysis

Top Queries to Ask About Beta Drugs Limited

More Details on This News

Beta Drugs Limited (BDL) has announced the closure of its trading window for all Directors, Officers, Designated Employees, their immediate relatives, and others covered under the company's Code for Prevention of Insider Trading. The trading window will be closed from January 1, 2026, and will reopen 48 hours after the declaration of the Unaudited Financial Results for the quarter ended December 31, 2025.

This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and NSE circular NSE/CML/2019/11 dated April 2, 2019, regarding trading restriction periods.

The company has informed the Listing Department of the National Stock Exchange of India Limited about this development.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Beta Drugs Limited

Discover more trending news on Prysm

View All